ClinVar Miner

Submissions for variant NM_001164508.2(NEB):c.18693G>C (p.Ala6231=)

gnomAD frequency: 0.00448  dbSNP: rs141338915
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000117729 SCV000233226 benign not specified 2015-02-13 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000117729 SCV000307269 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001082595 SCV000416899 benign Nemaline myopathy 2 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV000117729 SCV000528776 benign not specified 2016-07-08 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV001082595 SCV000640628 benign Nemaline myopathy 2 2024-02-01 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000587974 SCV000697808 benign not provided 2017-04-24 criteria provided, single submitter clinical testing Variant summary: The NEB c.18693G>C (p.Ala6231Ala) variant involves the alteration of a conserved nucleotide, resulting in a synonymous change that is located at the last nucleotide of exon 119, therefore suggesting the variant could affect splicing. One in silico tool (mutation taster) predicts a damaging outcome for this variant. 3/5 splice prediction tools predict an impact on normal splicing and ESE finder predicts that this variant may affect ESE site. However, these predictions have yet to be confirmed by functional studies. This variant was found in 703/120702 control chromosomes (16 homozygotes) from ExAC at a frequency of 0.0058243, which is approximately 2 times the estimated maximal expected allele frequency of a pathogenic NEB variant (0.0035355), suggesting this variant is likely a benign polymorphism. The variant is more common in East Asian sub-population with allele frequency of 4.7% (408/8614 chromosomes). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as "likely benign/benign." Therefore, the variant of interest has been classified as Benign.
Athena Diagnostics Inc RCV000587974 SCV001144709 benign not provided 2019-06-27 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002505045 SCV002810055 likely benign Nemaline myopathy 2; Arthrogryposis multiplex congenita 6 2022-04-06 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000117729 SCV000151980 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Natera, Inc. RCV001082595 SCV001453278 benign Nemaline myopathy 2 2020-09-16 no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV000587974 SCV001800226 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000587974 SCV001927750 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.